Brainard J A, Prayson R A, Barnett G H
Department of Anatomic Pathology, Brain Tumor and Neuro-Oncology Center, Cleveland (Ohio) Clinic Foundation, USA.
Arch Pathol Lab Med. 1997 May;121(5):481-4.
Use of the image-guided stereotactic brain biopsy has facilitated the diagnosis of previously inaccessible lesions with both safety and reliability. However, few studies have assessed the diagnostic yield of frozen section evaluation of the initial stereotactic target (FS-0). We describe our experience with 188 stereotactic brain biopsies in order to evaluate the diagnostic yield of FS-0.
Retrospective study of 188 stereotactic brain biopsies from 185 patients.
Tertiary referral center with a high volume of neurosurgical cases including image-guided stereotactic brain biopsies.
One hundred eighty-five patients who underwent imaged-guided stereotactic brain biopsy over a 58-month period.
The patients studied included 107 males and 78 females (mean age 48 years). Eleven (6%) biopsies were nondiagnostic. Diagnoses from FS-0 included a neoplastic condition in 96 (73%) of 131 cases and a nonneoplastic condition in 23 (50%) of 46 cases. In 119 (67%) of 177 cases, a diagnosis was reached at FS-0. A correct diagnosis was made on subsequent frozen section in 28 (16%) of cases, including 21 (16%) of 131 neoplasms and 7 (15%) of nonneoplastic conditions. In 15 (54%) of 28 cases, the correct diagnosis was made on the second frozen section; in 25 (89%) of 28, the correct diagnosis was made by the fourth frozen section. In 14 (11%) of 131 neoplastic cases, a sampling error relative to the lesion resulted in an inaccurate diagnosis at FS-0. A significant error in diagnosis occurred in three cases (1.7%).
We conclude that (1) because 58 (33%) of 177 diagnosed cases in our series would have been potentially misdiagnosed if only one biopsy had been taken at the stereotactic target, frozen section evaluation or cytologic examination of material at the time of surgery should be performed routinely to ensure that adequate tissue has been obtained for purposes of diagnosis; (2) taking up to four biopsies increases the diagnostic yield (from 67% to 89% in this series); and (3) neoplastic lesions are more likely to be definitively diagnosed at FS-0 than non-neoplastic lesions.
影像引导下的立体定向脑活检有助于安全可靠地诊断以前难以触及的病变。然而,很少有研究评估初始立体定向靶点的冰冻切片评估(FS-0)的诊断率。我们描述了188例立体定向脑活检的经验,以评估FS-0的诊断率。
对185例患者的188例立体定向脑活检进行回顾性研究。
一家三级转诊中心,有大量神经外科病例,包括影像引导下的立体定向脑活检。
185例在58个月期间接受影像引导下立体定向脑活检的患者。
研究的患者包括107名男性和78名女性(平均年龄48岁)。11例(6%)活检未得出诊断结果。FS-0的诊断结果包括131例中的96例(73%)为肿瘤性疾病,46例中的23例(50%)为非肿瘤性疾病。在177例中的119例(67%)中,FS-0时得出了诊断结果。在随后的冰冻切片中,28例(16%)做出了正确诊断,包括131例肿瘤中的21例(16%)和非肿瘤性疾病中的7例(15%)。在28例中的15例(54%)中,第二次冰冻切片做出了正确诊断;在28例中的25例(89%)中,第四次冰冻切片做出了正确诊断。在131例肿瘤病例中的14例(11%)中,相对于病变的采样误差导致FS-0时诊断不准确。3例(1.7%)出现了明显的诊断错误。
我们得出结论:(1)由于如果仅在立体定向靶点取一次活检,我们系列中的177例确诊病例中的58例(33%)可能会被误诊,因此手术时应常规进行冰冻切片评估或材料的细胞学检查以确保获取足够的组织用于诊断;(2)最多取4次活检可提高诊断率(本系列中从67%提高到89%);(3)肿瘤性病变比非肿瘤性病变更有可能在FS-0时得到明确诊断。